Jesus Ulloa

Efficacy and safety of autologous whole blood clot in diabetic foot ulcers: a randomised controlled trial

There were 199 patients assessed for study eligibility; 80 (40%) patients did not pass screening. The main reasons for screening failure included reduction by ≥30% of the ulcer area (post debridement)...